Author Guidelines
Instructions for Authors
Manuscript Preparation Guidelines
Originality and Authorship: Manuscripts must be original and must not have been published previously or be under consideration by another journal. Authors should disclose any related manuscripts, preprints, conference abstracts, or previously published material that may overlap with the submitted work.
All listed authors must have made substantial contributions to the work and approved the final manuscript. The corresponding author is responsible for communication with the journal and for confirming that all authors have approved the submission.
ORCID iDs are encouraged for all authors.
Cover Letter
The cover letter should briefly state:
- manuscript title;
- article type;
- principal contribution;
- confirmation that the manuscript is original;
- confirmation that it is not under consideration elsewhere;
- relevant ethical approval;
- conflicts of interest;
- funding information where applicable;
- any additional information the editors should consider.
The cover letter should not duplicate the entire abstract or manuscript.
Manuscript Preparation
- Manuscripts must be written in clear, concise English. Authors may use UK or US English consistently.
- Submit in Microsoft Word (.docx) format.
- Use 12-point Times New Roman, 1.5 line spacing, with 1-inch margins on all sides.
- Number all pages consecutively.
Arrange the manuscript in the following order:
- Title Page
- Abstract & Keywords
- Introduction
- Materials and Methods
- Results
- Discussion
- Conclusion
- Acknowledgments (optional)
- Conflicts of Interest
- Funding Statement
- Data Availability Statement
- References
- Figures & Tables (with captions)
Title Page
The title page must include:
- Full article title (concise, informative, without abbreviations)
- Full names of all authors
- Institutional affiliations (department, university/institute, city, country)
- Corresponding author’s email
- ORCID IDs (recommended)
- Author contributions (CRediT taxonomy recommended)
Abstract
- Structured or unstructured abstract of 150–250 words.
- No references or undefined abbreviations.
- Provide 4–6 keywords relevant to materials science and emerging technologies.
- Use controlled vocabulary where appropriate (e.g., “alternative medicine,” “complementary medicine,” “integrative medicine”).
Figures and Tables
- Figures must be high-resolution (300 dpi or higher).
- Use clear, descriptive captions.
- Tables should be editable, not images.
- All figures and tables must be cited in order within the text.
Ethical Policies
JIBM adheres to COPE guidelines on:
- Authorship
- Confirm originality and absence of plagiarism
- Data integrity
- A Data Availability Statement is mandatory
- Animal and human research ethics
- Ensure ethical approval for any biological or human-related experiments
- Disclose financial or competing interests
- Identify funding sources
- Obtain permissions for reproduced material
Authors must state compliance in the manuscript.
Reporting Guidelines
Authors should use appropriate reporting guidelines for their study design.
Examples include:
- CONSORT — randomized clinical trials
- STROBE — observational studies
- PRISMA — systematic reviews and meta-analyses
- STARD — diagnostic studies
- CARE — case reports
- ARRIVE — animal research
- TRIPOD — prediction models
Where applicable, the relevant checklist should be submitted with the manuscript.
Preprint Policy
Authors should disclose whether a manuscript or substantially similar version has previously appeared as a preprint. Posting a preprint does not by itself constitute prior journal publication, provided that the work complies with the journal's policies and applicable ethical and copyright requirements.
Authors should provide the preprint DOI or persistent identifier where available.
Permissions and Copyright
Authors are responsible for obtaining permission to reproduce copyrighted material owned by third parties.
This includes:
- previously published figures;
- tables;
- substantial quotations;
- photographs;
- proprietary datasets;
- other copyrighted content.
Appropriate attribution and permission documentation should be provided where required.
Artificial Intelligence and AI-Assisted Technologies
Authors remain fully responsible for the accuracy, originality, integrity, and final content of their manuscripts. AI-assisted technologies may be used for appropriate purposes such as language editing, grammar correction, or organizational assistance, provided that authors critically review the resulting content.
AI tools must not be listed as authors.
Where AI-assisted technology has materially contributed to manuscript preparation, authors should disclose the tool and describe its use in accordance with the journal's AI policy. Authors remain responsible for checking AI-assisted text, references, images, data, and interpretations for accuracy and originality.
The journal follows current medical-publishing principles that place responsibility on human authors and require transparency concerning substantive AI use.
Units, Symbols, and Nomenclature
- Use SI units for all measurements; provide SI equivalents if non-SI units are used.
- Define all abbreviations at first use and maintain consistent usage.
- Use Latin binomial names for organisms (italicized) following ICN rules.
- Chemical names should follow IUPAC recommendations.
- Provide scientific and common names for herbal/traditional medicines, including plant part used.
- Apply standard scientific notation and use a zero before decimals (e.g., 0.05).
- Use internationally accepted symbols (µg, mg/kg, °C) and avoid non-standard abbreviations.
- Use accepted clinical units (mmHg, bpm, L/min) consistently throughout the manuscript.
- Use standard statistical symbols (n, p, SD, SE, CI) and italicize variables (e.g., p < 0.05).
- Report units where applicable (e.g., bpm, %).
Funding
All sources of financial support should be disclosed. Authors should provide the name of the funding organization and, where applicable, grant number. If no specific funding was received, authors should provide an appropriate statement such as:
Funding: No specific funding was received for this study.
Reference & Citation Style: American Medical Association (AMA) – JIBM Standard
The Journal of Inflammation Biology and Medicine (JIBM) follows the American Medical Association (AMA) Manual of Style, 11th edition, in accordance with recommendations of the International Committee of Medical Journal Editors (ICMJE).
In-Text Citations
- References should be numbered consecutively in the order in which they first appear in the text.
- Use superscript Arabic numerals for citations in the text.
- Example:
Integrative therapies are increasingly used in chronic disease management.1
Several studies support this approach.2,3
Recent evidence highlights its clinical relevance.4–6
- Citations should appear in the order they are first mentioned in the text.
- Cite references after punctuation where necessary.
- The same reference number should be used for repeated citations
- Multiple citations should appear as :
Sequential: 2–5 (superscript)
Non-sequential: 2,7,9 (superscript)
Reference List Format
List references numerically in the order cited in the manuscript.
Journal titles in the reference list must be abbreviated according to the National Library of Medicine (NLM) Catalog.
- Use official NLM abbreviations, not personal or informal abbreviations
- Provide DOI whenever available.
- Author names: Surname + initials (no periods).
- Include all authors when six or fewer (if authors ≤6); for seven or more (if authors ≥7), list the first 3 authors followed by et al.
American Medical Association (AMA) Manual of Style, Examples (JIBM Standard)
a) Journal Articles
Author AA, Author BB, Author CC, et al. Article title: subtitle. Abbreviated Journal Title. Year;Volume(Issue):Page range. doi:10.xxxx/xxxxx
Example:
David K, Laurie NY, Ronni T, Mfopou YE. Inter-Cavitary Communications in Congenital Heart Disease: A Systematic Review and Integrated Meta-Analysis an Sub-Saharan Africa. J Case Rep Rev Med. 2026;2(3):1-6. doi: 10.64978/jcrrm.2026.09150129
b) Books
Author AA, Author BB, Author CC. Book Title. Edition or Volume. Publisher; Year.
Example:
Patterson JW. Weedon’s Skin Pathology. 4th ed. Churchill Livingstone; 2016.
c) Book Chapters
Author AA, Author BB, Author CC. Chapter title. In: Editor AA, Editor BB, Editor CC, eds. Book Title. Edition. Publisher; Year:Page range.
Example:
Boushey CJ. Application of research paradigms to nutrition practice. In: Coulston AM, Boushey CJ, Ferruzzi MG, eds. Nutrition in the Prevention and Treatment of Disease. 3rd ed. Academic Press; 2013:99-105.
d) Conference Presentation
Author AA, Author BB, Author CC. Paper title. Paper presented at: Meeting Name; Meeting dates; Meeting location. Accessed Month Day, Year. URL
Example:
Morales M, Zhou X. Health practices of immigrant women: indigenous knowledge in an urban environment. Paper presented at: 78th Association for Information Science and Technology Annual Meeting; November 6-10, 2015; St Louis, MO. Accessed March 15, 2016. https://www.asist.org/files/meetings/am15/proceedings/openpage15.html.
e) Conference Proceedings (Published Online)
Author(s). Title of paper. In: Title of Proceedings. Publisher; Year. doi:10.xxxx/xxxxx
Example:
Wilson J, Ahmed N, Lee K. Immune signaling and therapeutic response in inflammatory disorders. In: Proceedings of the World Congress of Immunology. Elsevier; 2025. doi:10.xxxx/xxxxx
f) Website / Online Source
Author AA, Author BB, Author CC. Title of specific item cited or name of the organisation responsible for the site. Site Name. Accessed Month Day, Year. URL
Example:
International Society for Infectious Diseases. ProMED-mail. Accessed February 10, 2016. http://www.promedmail.org
Charlton G. Internal linking for SEO: examples and best practices. Search Engine Watch. Accessed February 10, 2016. https://www.searchenginewatch.com/sew/how-to/2428041/internal-linking-for-seo-examples-and-best-practices
g) Preprint
Author AA, Author BB. Title of article. Preprint. Name of repository. Published date. doi:
Example:
Smith AB, Jones CD. Inflammatory biomarkers in chronic disease. Preprint. medRxiv. Published January 12, 2026. doi:10.1101/2026.01.10.123456
Journal Abbreviations:
Use standard journal abbreviations as indexed in PubMed / MEDLINE.
Example:
Journal of Inflammation Biology and Medicine → J Inflamm Biol Med
Inflammation Biology and Medicine → Inflamm Biol Med
Unpublished and Personal Communications
Avoid citing unpublished data.
Personal communications should be cited only in the text, not in the reference list.
Preprints (Optional Policy – you can include or exclude)
If allowed :
- Clearly label as preprint
- Include repository name and DOI
Reference Management Tools
Authors are encouraged to use:
- EndNote
- Zotero
- Mendeley
Ensure the selected style is set to Vancouver before submission.
Submission Process
Required Files :
Please submit:
- Manuscript (Word format preferred)
- Cover letter
- Figures (if separate)
- Supplementary material (if any)
Manuscripts must be submitted through the JIBM Online Submission System.
Online Submission : https://www.scivolve.com/inflammation-biology/manuscriptsubmission
Email Submission (optional): manuscripts@scivolve.com
Authors may also submit their manuscript as an email attachment to the address above if needed.
- Cover Letter : A cover letter must accompany the manuscript submission. The cover letter should briefly describe the significance of the research, the contribution it makes to the field, and why it is suitable for publication in a SCIVOLVE journal. Authors should also confirm that the manuscript is not under consideration for publication elsewhere.
- All submissions undergo double-blind peer review.
- Average initial decision time: 2-3 weeks.
- Revised manuscripts must include a point-by-point response to reviewers.
Final Checks Before Submission
Authors should ensure:
- All references are cited in the text
- Citation numbers are in correct order
- Formatting follows Vancouver style strictly
- DOIs are included where available
- Journal names are properly abbreviated
- All figures and tables are included and properly labeled
Article Types Accepted
- Research Articles
- Review Articles (Systematic/Narrative)
- Short Communications
- Case Reports
- Case Series
- Clinical Images
- Editorials
- Perspective Articles
- Commentary Articles
- Brief Reports
- Letters to the Editor
Article Processing Charges (APC)
To support open-access publishing and sustainable editorial operations, the Journal of Inflammation Biology and Medicine applies an Article Processing Charge (APC) of USD 1570 per accepted manuscript.
- APC is payable only after acceptance.
- No submission fees apply.
- Waivers or discounts may be considered for authors from low-income regions.
Article Publishing Charges - Author Location
| USA/Canada/Rest-of-World ($) | UK - British Pound (£) | Eurozone - Euro (€) |
| US$ 1530.00 | £ 1140.00 | € 1330.00 |
Open Access and Licensing
SCIVOLVE operates under an open access model, ensuring that all published articles are freely accessible to the global research community. Authors retain copyright of their work and can choose from a range of Creative Commons Licenses to determine how their work can be used by others.
Appeals and Complaints
Appeals
Authors who believe that their manuscript was unfairly rejected may submit an appeal to the editorial office. The appeal must be based on a substantive disagreement with the reviewers’ comments or the editorial decision. Appeals will be considered by a senior editor or an independent reviewer.
Complaints
Any complaints regarding the editorial process, peer review, or publication ethics should be directed to the SCIVOLVE editorial office. We take all complaints seriously and will investigate any concerns promptly and transparently.
Contact Information
For any questions or further assistance, please contact the journal editorial office at editorialoffice@scivolve.com or visit our website.
COPYRIGHT STATEMENT
As an author submitting a manuscript to SCIVOLVE Journals, you retain full copyright of your work. Upon acceptance and publication, your article will be freely available to the public under the terms of the Creative Commons Attribution (CC BY) License. This allows unrestricted use, distribution, and reproduction, in any medium, provided the original work is properly cited.
Author's Rights
Copyright Ownership: Authors generally retain copyright of their work. They grant the journal a license to publish, which allows the journal to distribute the work under an open-access model.
Access and Distribution
Authors have the right to access their published work freely and may distribute it according to the journal’s open-access policy, including posting on websites, repositories, and social media.
Re-use of Work
Authors typically have the right to use their published work in future publications or presentations, provided they comply with the journal’s licensing terms, which often require proper citation.
Attribution
Authors should be credited appropriately when their work is used or referenced, as specified by the Creative Commons license or other licensing agreements adopted by the journal.
License Information
All content published by SCIVOLVE is licensed under the Creative Commons Attribution 4.0.
International License
(CC BY 4.0). This license allows others to:
Share
Copy and redistribute the material in any medium or format.
Adapt
Remix, transform, and build upon the material for any purpose, even commercially.
Attribution
You must give appropriate credit to the original author(s) of the work, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
Full License Text
You can view the full terms of the Creative Commons Attribution 4.0 International License at: https://creativecommons.org/licenses/by/4.0/
Third-Party Content
Some content published by SCIVOLVE may include materials from third parties. Such content remains the property of the original copyright holders and may be subject to different licensing terms. Authors are responsible for ensuring that they have the appropriate permissions for any third-party materials included in their submissions.
Infringement Notification
If you believe that any content on SCIVOLVE's website infringes your copyright, please contact us with the following details:
- Description of the copyrighted work you claim has been infringed.
- Description of the location of the allegedly infringing content on our site.
- Your contact details (name, address, phone number, email address).
- A statement that you have a good faith belief that the use is not authorized by the copyright owner, its agent, or the law.
- A statement under penalty of perjury that the information provided is accurate and that you are the copyright owner or authorized to act on their behalf.
Changes to This Copyright Statement
SCIVOLVE may update this Copyright Statement periodically. We will post the updated statement on our website, and the "Last Updated" date will be revised. Continued use of our website and services signifies acceptance of the changes.
Contact Information:
For questions regarding this Copyright Statement, please contact:
SCIVOLVE
Editorial Team
Email: editorialoffice@scivolve.com
This work is protected by national and international copyright laws. All rights reserved.
© 2026 SCIVOLVE. All rights reserved.